Furthermore, in human ovarian cancer cells (OV17-1) a neutralizing antibody blocking ICAM-1 ameliorated the enhanced CTL lysis seen with Ang1 and Ang2 inhibitors, demonstrating that ICAM-1 was mechanistically involved in the increase in antigen-specific T-cell lysis (Fig. 5). Here, ANGPT1 is linked to ovarian carcinoma.